Please see below for frequently asked questions about the International Symposium on ALS/MND. If you can't find an answer to your question below, please do not hesitate to contact us.
The 30th International Symposium on ALS/MND has been approved by the Federation of the Royal College of Physicians of the United Kingdom for 18 category 1 (external) CPD credits.
An application has been made to the UEMS EACCME® for CME accreditation of this year’s event.
Poster and Poster Prize information
Note that if there is a change in presenting author you must let us know as soon as possible by emailing firstname.lastname@example.org. This includes instances when someone is presenting on your behalf or you are no longer able to attend.
The Poster Prize is awarded to two presenting authors of the best biomedical and clinical posters. Find out more about eligibility on the Poster Prize page.
Posters should be paper size A0 (841 x 1189mm; size E by American National Standards Institute) in a portrait orientation.
26 John Street, Northbridge, WA 6003
Visit their website at: http://tmp.vanguardpress.com.au/
Please mention that ‘MND Western Australia’ recommended you.
The submission deadline for abstracts was on 5 June 2019, 23:59 UK time.
The Programme Committee will review all submitted abstracts during June. All corresponding authors will be notified about their abstract decision by the end of July.
Abstracts can be withdrawn on or before 2 August 2019. Any abstracts withdrawn after this date will still be published in the journal supplement.
Accepted abstracts will be available to view on our website in November. Abstracts for the platform and poster presentations will be published in the online only version of the ‘Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration’ journal supplement. Work in Progress/Care Practice abstracts will be available to download from our website as a PDF document and will not be published in the ALS&FD journal supplement.
The draft programme will be available on our website in early August.
Each year, we have one or two slots reserved for news on results. For example, from a Phase 3 clinical trial, new gene discovery or similar; these are highly competitive, and there is therefore no guarantee of securing a slot. A short abstract must be submitted no later than the end of September to email@example.com.
We do not offer a day rate, as delegates are expected to attend all three days of the conference.
There are no reduced rates for students. We advise that they register as soon as possible to get the early bird rate of £400 (deadline 27 August).
People with MND will be charged the early bird (discounted) rate of £400 (which will be available throughout the year), and one accompanying carer will be able to attend for free. Please email firstname.lastname@example.org for more details.
Please email your request to our conference team at email@example.com.